Stay updated on FLT3 Inhibitor Combo in AML Clinical Trial

Sign up to get notified when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FLT3 Inhibitor Combo in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-03T23:25:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide notice explains NIH’s transition to using “Super Intelligence” alongside “Artificial Intelligence,” and the website revision changes from v3.7.1 to v3.7.2.
    Difference
    0.3%
    Check dated 2026-10-20T23:07:39.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-07T00:13:54.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0 instead of v3.6.6, representing an update to the site’s interface/version for the study history page. The change does not modify the underlying study data.
    Difference
    0.0%
    Check dated 2026-09-15T22:06:38.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.5 to v3.6.6, indicating a new version of the page without altering substantive content.
    Difference
    0.0%
    Check dated 2026-09-01T20:53:38.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page now displays an updated platform release version, indicating Revision: v3.6.5 replacing the previous v3.6.4. This reflects a minor site maintenance update and does not alter the study record content.
    Difference
    0.0%
    Check dated 2026-08-11T21:38:47.000Z thumbnail image

Stay in the know with updates to FLT3 Inhibitor Combo in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.